30. Thomas C, Bhatia S. Cancer: brain-regulated biphasic stress response induces cell growth or cell death to adapt to psychological stressors. Adv Mind Body Med 2014; 28(3): 14–21.
31. Kennedy B, Valdimarsdpttir U, Sundstrom K, Sparen P, Lambe M, Fall K, Fang F. Loss of a parent and the risk of cancer in early life: a nationwide cohort study. Cancer Causes Control 2014; 25(4): 499–506.
32. Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res 2014; 58(2): 193–210.
33. Himmerich H, Fischer J, Bauer K, Kirkby KC, Sack U, Krugel U. Stress-induced cytokine changes in rats. Eur Cytokine Netw 2013; 24(2): 97–103.
34. Sinnia S, De`Ambrosis B. Stress and melanoma: increasing the evidence towards a causal basis. Arch Dermatol Res 2013; 305(9): 851–6.
35. Lisa M Jaremka, Christopher P Fagundes, Juan Peng, Jeanette M Bennett, Ronald Glaser, William B Malarkey, Janice K Kiecolt-Glaser. Loneliness promotes inflammation during acute stress. Psychol Sci 2013; 24(7); doi 10.1177/0956797612464059.
36. Benjamin P Chapman, Kelvin Fiscella, Ichiro Kawachi, Paul Duberstein, Peter Muennig. Emotion suppression and mortality risk over 12-year follow-up. J Psycosom Res 2013; 75(4): 381–385.
37. Mund M, Mitte K. The costs of repression: a meta-analysis on the relation between repressive coping and somatic diseases. Health Psychol 201110.1037/a0026257.
38. Consedine NS, Magai C, Bonanno GA. Moderators of the emotion-inhibition-health relationship: a review and research agenda. Review of General Psychology 2002; 6(2): 204–28.
39. Cramer P. Stress, autonomic nervous system reactivity, and defense mechanisms. In: Hentchel, U; Clinical Perspectives. Elsevier 2004; p 325–50.
40. Giese-Davis J, DiMiceli S, Sephton SE, Spiegel D. Emotional epression and diurnal cortisol slope in women with metastatic breast cancer in supportive-expressive group therapy. Biol Psychol 2006; 73(2): 190–8.
41. Giese-Davis JSS, Abercrombie HC, Duran REF, Spiegel D. Repression and high anxiety are associated with aberrant diurnal cortiol rhythms in women with metastatic breast cancer. Health Psychology 2004; 23(6): 645–50.
42. Hentschel U, Smith G, Draguns JG. Defence mechanisms: theoretical, research, and clinical perspectives. Amsterdam: Elsevier 2004. Defense mechanisms and their psychophysiological correlates.
43. Singer JL, editor. Repression and dissociation: implications for personality theory, psychopathology, and health. Chicago, IL: University of Chicago Press; 1995.
44. Korte SM, Koolhaas JM, Wingfield JC, McEwen BS. The Darwinian concept of stress; benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev 2005; 29(1): 3–38.
45. Grossarth-Maticek R, Bastiaans J, Kanazir DT. Psychosocial factors as strong predictors of mortality from cancer, ischaemic heart disease and stroke: the Yugoslav prospective study. J Psychosom Res 1985; 29(2): 167–76.
46. Grossarth-Maticek R. Psychosocial predictors of cancer and internal diseases. An overview. Psychother Psychosom 1980; 33(3): 122–8.
47. Fox BH, Temoshok L, Dreher H. Mind-body and behavior in cancer incidence. Advances 1988; 5(4): 41–6.
48. Butow PN, Hiller JE, Price MA, Thackway SV, Kricker A, Tennant CC. Epidemiological evidence for a relationship between life events, coping stylt, and personality factors in the development of breast cancer. J Psychosom Res 2000; 49(3): 169–81.
49. MvKenna MC, Zevon MA, Corn B, Rounds J. Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 1999; 18(5): 520–31.
50. Harburg E, Julius M, Kaciroti N, Gleiberman L, Schork MA. Expressive/suppressive anger-coping responses, gender, and types of mortality: a 17-year follow-up. Psychosom Med 2003; 65(4): 588–97.
51. Denollet J, Gidron Y, Vrints CJ, Conraads VM. Anger, suppressed anger, and risk of adverse events in patients with coronary artery disease. Am J Cardiol 2010; 105(11): 1555–60.
52. Sturmer T, Hasselbach P, Amelang M. Personality, lifestyle, and risk of cardiovascular disease and cancer: follow-up of population based cohort. BMJ 2006; 332(7554): 1359.
53. Pauwels EK, Volterrani D, Mariani G, Kostkiewics M. Mozart, music and medicine. Med Princ Pract 2014; 23(5): 403–12.
54. Baltrush HJ, Stangel W, Titze I. Stress, cancer and immunity. New developments in biopsychosocial and psychoneuroimmunologic research. Acta Neurol (Napoli) 1991; 13(4): 315–27.
55. Tashiro M, Itoh M, Kubota K, Kumano H, Masud MM, Moser E, Arai H, Sasaki H. Relationship between trait anxiety, brain activity and natural killer cell activity in cancer patients: a preliminary PET study. Psychooncology 2001; 10(6): 541–6.
56. House JS, Landis KR, Umberson D. Social relationship and health. Science 1988; 241: 540–5.
57. Reynolds P, Kaplan GA. Social connections and risk for cancer: prospective evidence from the Alameda county study. Behav Med 1990; 16: 101–10.
58. Phillips DP, Van Voorhees CA, Ruth TE. The birthday: lifeline or deadline? Psychosom Med 1992; 54: 532–42.
59. Phillips DP, Ruth TE, Wagner LM. Psychology and survival. Lancet 1993; 342: 1142–5.
60. Penninx BW. Chronically depressed mood and cancer risk in older persons. Journal of the National Cancer Institute 1998; 90: 1888–93.
61. Giese-Davis J, Collie K, Rancourt KM, et al. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncology 2011; 29: 413–20.
62. Spiegel D, Bloom JR, Yalom I. Group support for patients with metatatic cancer. A randomized outcome study. Arch Gen Psychiatry 1981; 38: 527–533.
63. Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 1983; 45: 333–9.
64. Andersen BL, Yang HC, Farrar WB, et al. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 2008; 113: 3450–8.
65. Andersen BL, Thornton LM, Shapiro CL, et al. Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clin Cancer Research 16: 3270–8.
66. Spiegel D. A 43-year-old womancoping with cancer. JAMA 1999; 282: 371–8.
